ZYNERBA PHARMACEUTICALS, INC. Operating Income
ZYNERBA PHARMACEUTICALS, INC. reported Operating Income of -$11.14 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2023-08-14
- ZYNERBA PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2023-06-30 was -$11.14M.
- ZYNERBA PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2023-03-31 was -$10.47M.
- ZYNERBA PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2022-12-31 was -$8.69M.
- ZYNERBA PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2022-09-30 was -$8.49M.
- ZYNERBA PHARMACEUTICALS, INC. operating income (loss) for fiscal 2022 was -$35.25M.
- ZYNERBA PHARMACEUTICALS, INC. operating income (loss) for fiscal 2021 was -$36.77M.
- ZYNERBA PHARMACEUTICALS, INC. operating income (loss) for fiscal 2020 was -$52.06M.
- ZYNERBA PHARMACEUTICALS, INC. operating income (loss) for fiscal 2019 was -$34.32M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$11.14M 10-Q · filed 2023-08-14 | -$21.61M 10-Q · filed 2023-08-14 | -$30.29M derived: sum of 3 quarters · filed 2023-08-14 | -$38.79M derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | -$10.47M 10-Q · filed 2023-05-15 | -$19.16M derived: sum of 2 quarters · filed 2023-05-15 | -$27.65M derived: sum of 3 quarters · filed 2023-05-15 | -$36.82M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | -$8.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$17.18M derived: sum of 2 quarters · filed 2023-03-28 | -$26.35M derived: sum of 3 quarters · filed 2023-08-14 | -$35.25M 10-K · filed 2023-03-28 |
| 2022-09-30 | -$8.49M 10-Q · filed 2022-11-14 | -$17.66M derived: sum of 2 quarters · filed 2023-08-14 | -$26.57M 10-Q · filed 2022-11-14 | -$35.40M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | -$9.17M 10-Q · filed 2023-08-14 | -$18.07M 10-Q · filed 2023-08-14 | -$26.91M derived: sum of 3 quarters · filed 2023-08-14 | -$37.12M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$8.90M 10-Q · filed 2023-05-15 | -$17.74M derived: sum of 2 quarters · filed 2023-05-15 | -$27.95M derived: sum of 3 quarters · filed 2023-05-15 | -$37.79M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$8.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$19.05M derived: sum of 2 quarters · filed 2023-03-28 | -$28.89M derived: sum of 3 quarters · filed 2023-03-28 | -$36.77M 10-K · filed 2023-03-28 |
| 2021-09-30 | -$10.21M 10-Q · filed 2022-11-14 | -$20.05M derived: sum of 2 quarters · filed 2022-11-14 | -$27.93M 10-Q · filed 2022-11-14 | -$38.12M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$9.84M 10-Q · filed 2022-08-10 | -$17.72M 10-Q · filed 2022-08-10 | -$27.91M derived: sum of 3 quarters · filed 2022-08-10 | -$37.14M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$7.88M 10-Q · filed 2022-05-16 | -$18.07M derived: sum of 2 quarters · filed 2022-05-16 | -$27.31M derived: sum of 3 quarters · filed 2022-05-16 | -$49.15M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$10.19M 10-K · filed 2021-03-10 | -$19.42M derived: sum of 2 quarters · filed 2021-11-15 | -$41.26M derived: sum of 3 quarters · filed 2021-11-15 | -$52.06M 10-K · filed 2023-03-28 |
| 2020-09-30 | -$9.23M 10-Q · filed 2021-11-15 | -$31.07M derived: sum of 2 quarters · filed 2021-11-15 | -$41.87M 10-Q · filed 2021-11-15 | -$53.29M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$21.84M 10-Q · filed 2021-08-09 | -$32.64M 10-Q · filed 2021-08-09 | -$44.06M derived: sum of 3 quarters · filed 2021-08-09 | -$45.98M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | -$10.80M 10-Q · filed 2021-05-12 | -$22.22M derived: sum of 2 quarters · filed 2021-05-12 | -$24.14M derived: sum of 3 quarters · filed 2021-05-12 | -$35.65M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$11.42M 10-K · filed 2021-03-10 | -$13.34M derived: sum of 2 quarters · filed 2021-03-10 | -$24.85M derived: sum of 3 quarters · filed 2021-03-10 | -$34.32M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$1.93M 10-K · filed 2021-03-10 | -$13.44M derived: sum of 2 quarters · filed 2021-03-10 | -$22.90M 10-Q · filed 2020-11-09 | -$30.95M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | -$11.51M 10-K · filed 2021-03-10 | -$20.98M 10-Q · filed 2020-08-10 | -$29.02M derived: sum of 3 quarters · filed 2021-03-10 | -$37.01M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | -$9.47M 10-K · filed 2021-03-10 | -$17.51M derived: sum of 2 quarters · filed 2021-03-10 | -$25.50M derived: sum of 3 quarters · filed 2021-03-10 | -$37.47M derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | -$8.05M 10-K · filed 2020-03-10 | -$16.03M derived: sum of 2 quarters · filed 2020-03-10 | -$28.00M derived: sum of 3 quarters · filed 2020-03-10 | -$40.40M 10-K · filed 2021-03-10 |
| 2018-09-30 | -$7.99M 10-K · filed 2020-03-10 | -$19.96M derived: sum of 2 quarters · filed 2020-03-10 | -$32.35M 10-Q · filed 2019-11-06 | -$40.56M derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-06-30 | -$11.97M 10-K · filed 2020-03-10 | -$24.37M 10-Q · filed 2019-08-06 | -$32.57M derived: sum of 3 quarters · filed 2020-03-10 | -$41.12M derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-03-31 | -$12.40M 10-K · filed 2020-03-10 | -$20.60M derived: sum of 2 quarters · filed 2020-03-10 | -$29.15M derived: sum of 3 quarters · filed 2020-03-10 | -$37.52M derived: sum of 4 quarters · filed 2020-03-10 |
| 2017-12-31 | -$8.20M 10-K · filed 2019-03-11 | -$16.75M derived: sum of 2 quarters · filed 2019-03-11 | -$25.12M derived: sum of 3 quarters · filed 2019-03-11 | -$32.82M 10-K · filed 2020-03-10 |
| 2017-09-30 | -$8.55M 10-K · filed 2019-03-11 | -$16.92M derived: sum of 2 quarters · filed 2019-03-11 | -$24.62M 10-Q · filed 2018-11-08 | -$31.30M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-06-30 | -$8.37M 10-K · filed 2019-03-11 | -$16.07M 10-Q · filed 2018-08-02 | -$22.75M derived: sum of 3 quarters · filed 2019-03-11 | -$28.75M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-03-31 | -$7.70M 10-K · filed 2019-03-11 | -$14.39M derived: sum of 2 quarters · filed 2019-03-11 | -$20.39M derived: sum of 3 quarters · filed 2019-03-11 | -$26.67M derived: sum of 4 quarters · filed 2019-03-11 |
| 2016-12-31 | -$6.68M 10-K · filed 2018-03-12 | -$12.68M derived: sum of 2 quarters · filed 2018-03-12 | -$18.97M derived: sum of 3 quarters · filed 2018-03-12 | -$23.21M 10-K · filed 2019-03-11 |
| 2016-09-30 | -$6.00M 10-K · filed 2018-03-12 | -$12.28M derived: sum of 2 quarters · filed 2018-03-12 | -$16.52M 10-Q · filed 2017-11-14 | -$21.94M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | -$6.28M 10-K · filed 2018-03-12 | -$10.53M 10-Q · filed 2017-08-01 | -$15.94M derived: sum of 3 quarters · filed 2018-03-12 | -$19.94M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | -$4.24M 10-K · filed 2018-03-12 | -$9.66M derived: sum of 2 quarters · filed 2018-03-12 | -$13.65M derived: sum of 3 quarters · filed 2018-03-12 | -$15.28M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | -$5.42M 10-K · filed 2017-03-27 | -$9.41M derived: sum of 2 quarters · filed 2017-03-27 | -$11.04M derived: sum of 3 quarters · filed 2017-03-27 | -$12.53M 10-K · filed 2018-03-12 |
| 2015-09-30 | -$4.00M 10-K · filed 2017-03-27 | -$5.62M derived: sum of 2 quarters · filed 2017-03-27 | -$7.12M 10-Q · filed 2016-11-14 | -$8.52M derived: sum of 4 quarters · filed 2017-03-27 |
| 2015-06-30 | -$1.63M 10-K · filed 2017-03-27 | -$3.12M 10-Q · filed 2016-08-11 | -$4.52M derived: sum of 3 quarters · filed 2017-03-27 | -$7.04M derived: sum of 4 quarters · filed 2017-03-27 |
| 2015-03-31 | -$1.49M 10-K · filed 2017-03-27 | -$2.90M derived: sum of 2 quarters · filed 2017-03-27 | -$5.41M derived: sum of 3 quarters · filed 2017-03-27 | -$6.92M derived: sum of 4 quarters · filed 2017-03-27 |
| 2014-12-31 | -$1.40M 10-K · filed 2016-03-14 | -$3.92M derived: sum of 2 quarters · filed 2016-03-14 | -$5.43M derived: sum of 3 quarters · filed 2016-03-14 | -$5.67M 10-K · filed 2017-03-27 |
| 2014-09-30 | -$2.51M 10-K · filed 2016-03-14 | -$4.02M derived: sum of 2 quarters · filed 2016-03-14 | -$4.26M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | -$1.51M 10-K · filed 2016-03-14 | -$1.75M 10-Q · filed 2015-08-27 | ||
| 2014-03-31 | -$239.14K 10-K · filed 2016-03-14 | |||
| 2013-12-31 | -$634.44K 10-K · filed 2016-03-14 |